1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1:1311–5.
Article
2. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol. 1986; 39:353–65.
3. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis. 1990; 161:626–33.
4. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991; 325:1127–31.
5. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994; 330:1267–71.
6. Perri F, Quitadamo M, Ricciardi R, Piepoli A, Cotugno R, Gentile A, et al. Comparison of a monoclonal antigen stool test (Hp StAR) with the 13C-urea breath test in monitoring Helicobacter pylori eradication therapy. World J Gastroenterol. 2005; 11:5878–81.
7. Nakata H, Itoh H, Ishiguchi T, Iwata T, Sato H, Higashimoto Y, et al. Immunological rapid urease test using monoclonal antibody for Helicobacter pylori. J Gastroenterol Hepatol. 2004; 19:970–4.
8. Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med. 1996; 41:85–117.
9. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol. 2001; 19:523–63.
10. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med. 1998; 188:2277–88.
11. Ferrero RL, Labigne A. Helicobacter pylori vaccine development in the post-genomic era: can in silico translate to in vivo. Scand J Immunol. 2001; 53:443–8.
12. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA. 1995; 92:6499–503.
13. Hocking D, Webb E, Radcliff F, Rothel L, Taylor S, Pinczower G, et al. Isolation of recombinant protective Helicobacter pylori antigens. Infect Immun. 1999; 67:4713–9.
14. Choi SS, Chi WJ, Lee JH, Kang SS, Jeong BC, Hong SK. Overexpression of the sprD gene encoding Streptomyces griseus protease D stimulates actinorhodin production in Streptomyces lividans. J Microbiology. 2001; 39:305–13.
15. Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell Immunol. 1999; 191:74–80.
16. Lee JH. Cloning and expression of Mammaglobin gene. Korean J Food Nutr. 2004; 17:47–52.
17. Ndip RN, Malange AE, Akoachere JF, MacKay WG, Titanji VP, Weaver LT. Helicobacter pylori antigens in the faeces of asymptomatic children in the Buea and Limbe health districts of Cameroon: a pilot study. Trop Med Int Health. 2004; 9:1036–40.
18. Kim PS, Lee JW, Pai SH, Kim YB, Cho JK, Lee DH, et al. Detection of Helicobacter pylori Antigen in Stool by Enzyme Immunoassay. Yonsei Med J. 2002; 43:7–13.
19. Kimmel B, Bosserhoff A, Frank R, Gross R, Goebel W, Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun. 2000; 68:915–20.
20. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999; 397:176–80.
21. Sabarth N, Hurwitz R, Meyer TF, Bumann D. Multiparameter Selection of Helicobacter pylori Antigens Identifies Two Novel Antigens with High Protective Efficacy. Infect Immun. 2002; 70:6499–503.
22. Asahi M, Tanaka Y, Izumi T, Ito Y, Naiki H, Kersulyte D, et al. Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo. Helicobacter. 2003; 8:1–14.
23. Haas G, Karaali G, Ebermayer K, Metzger WG, Lamer S, Zimny-Arndt U, et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics. 2002; 2:313–24.
24. Bumann D, Aksu S, Wendland M, Janek K, Zimny-Arndt U, Sabarth N, et al. Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect Immun. 2002; 70:3396–403.
25. Cao P, McClain MS, Forsyth MH, Cover TL. Extracellular release of antigenic proteins by Helicobacter pylori. Infect Immun. 1998; 66:2984–6.
26. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA. 1993; 90:5791–5.
27. McAtee CP, Lim MY, Fung K, Velligan M, Fry K, Chow T, et al. Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis, and serum profiling. Clin Diagn Lab Immunol. 1998; 5:537–42.